Advanced search
Publication Cover
Acta Oncologica Volume 57, 2018 - Issue 2
Journal homepage
3,181
Views
51
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: BIOBANKING

Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative

R. R. J. Coebergh van den BraakDepartment of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands; ORCID Iconhttp://orcid.org/0000-0001-9310-6629View further author information
ORCID Icon,
L. B. van RijssenDepartment of Surgery, Academic Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; ORCID Iconhttp://orcid.org/0000-0001-5918-1772View further author information
ORCID Icon,
J. J. van KleefDepartment of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands; View further author information
,
G. R. VinkNetherlands Comprehensive Cancer Organization, Utrecht, The Netherlands; ;Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; ORCID Iconhttp://orcid.org/0000-0002-6731-9660View further author information
ORCID Icon,
M. BerbeeDepartment of Radiation Oncology, Maastro Clinic, Maastricht, The Netherlands; View further author information
,
M. I. van Berge HenegouwenDepartment of Surgery, Academic Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; View further author information
,
H. J. BloemendalDepartment of Medical Oncology, Meander Medisch Centrum, Amersfoort, The Netherlands; View further author information
,
M. J. BrunoDepartment of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands; View further author information
,
M. C. BurgmansDepartment of Radiology, Leiden University Medical Center, Leiden, The Netherlands; View further author information
,
O. R. C. BuschDepartment of Surgery, Academic Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; View further author information
,
P. P. L. O. CoeneDepartment of Surgery, Maasstad Hospital, Rotterdam, The Netherlands; View further author information
,
V. M. H. CoupéDepartment of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; View further author information
,
J. W. T. DekkerDepartment of Surgery, Reinier de Graaf Hospital, Delft, The Netherlands; View further author information
,
C. H. J. van EijckDepartment of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands; View further author information
,
M. A. G. ElferinkNetherlands Comprehensive Cancer Organization, Utrecht, The Netherlands; View further author information
,
F. L. G. ErdkampDepartment of Medical Oncology, Zuyderland Medisch Centrum, Heerlen, The Netherlands; View further author information
,
W. M. U. van GrevensteinDepartment of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands; View further author information
,
J. W. B. de GrootDepartment of Medical Oncology, Isala, Zwolle, The Netherlands; View further author information
,
N. C. T. van GriekenDepartment of Pathology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; View further author information
,
I. H. J. T. de HinghDepartment of Surgery, Catharina Hospital, Eindhoven, The Netherlands; View further author information
,
M. C. C. M. HulshofDepartment of Radiotherapy, Academic Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; View further author information
,
J. N. M. IjzermansDepartment of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands; ORCID Iconhttp://orcid.org/0000-0003-3558-1039View further author information
ORCID Icon,
L. KwakkenbosLiving with Hope, Heemstede, The Netherlands; View further author information
,
V. E. P. P. LemmensNetherlands Comprehensive Cancer Organization, Utrecht, The Netherlands; View further author information
,
M. LosDepartment of Medical Oncology, St. Antonius Hospital, Nieuwegein, The Netherlands; View further author information
,
G. A. MeijerDepartment of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; ORCID Iconhttp://orcid.org/0000-0003-0057-0938View further author information
ORCID Icon,
I. Q. MolenaarDepartment of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands; View further author information
,
G. A. P. NieuwenhuijzenDepartment of Surgery, Catharina Hospital, Eindhoven, The Netherlands; View further author information
,
M. E. de NooDepartment of Surgery, Deventer Hospital, Deventer, The Netherlands; ORCID Iconhttp://orcid.org/0000-0002-5414-7046View further author information
ORCID Icon,
L. V. van de Poll-FranseResearch Department, Tilburg University, Tilburg, The Netherlands; View further author information
,
C. J. A. PuntDepartment of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands; ORCID Iconhttp://orcid.org/0000-0003-0846-1445View further author information
ORCID Icon,
R. C. RietbroekDepartment of Medical Oncology, Rode Kruis Hospital, Beverwijk, The Netherlands; View further author information
,
W. W. H. RoeloffzenDepartment of Medical Oncology, Treant Zorggroep, Hoogeveen, The Netherlands; View further author information
,
T. RozemaDepartment of Radiotherapy, Instituut Verbeeten, Tilburg, The Netherlands; View further author information
,
J. P. RuurdaDepartment of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands; View further author information
,
J. W. van SandickDepartment of Surgery, Netherlands Cancer Institute – Antoni van Leeuwenhoek, Amsterdam, The Netherlands; View further author information
,
A. H. W. SchiphorstDepartment of Surgery, Diakonessenhuis, Utrecht, The Netherlands; View further author information
,
H. SchipperStichting voor Patiënten met Kanker aan het Spijsverteringskanaal (SPKS), Utrecht, The Netherlands; View further author information
,
P. D. SiersemaDepartment of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands; ORCID Iconhttp://orcid.org/0000-0002-6940-8499View further author information
ORCID Icon,
M. SlingerlandDepartment of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands; View further author information
,
D. W. SommeijerDepartment of Medical Oncology, Flevoziekenhuis, Almere, The Netherlands; View further author information
,
M. C. W. SpaanderDepartment of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands; View further author information
,
M. A. G. SprangersDepartment of Medical Psychology, Academic Medical Center, Amsterdam, The Netherlands; View further author information
,
H. B. A. C. StockmannDepartment of Surgery, Kennemer Gasthuis, Haarlem, The Netherlands; View further author information
,
M. StrijkerDepartment of Surgery, Academic Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; View further author information
,
G. van TienhovenDepartment of Radiotherapy, Academic Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; View further author information
,
L. M. TimmermansStichting voor Patiënten met Kanker aan het Spijsverteringskanaal (SPKS), Utrecht, The Netherlands; View further author information
,
M. L. R. Tjin-a-TonDepartment of Medical Oncology, Hospital Rivierenland, Tiel, The Netherlands; View further author information
,
A. M. T. van der VeldenDepartment of Medical Oncology, Tergooi Hospital, Hilversum, The Netherlands; View further author information
,
M. J. VerhaarDepartment of Medical Oncology, Zuwe Hofpoort Hospital, Woerden, The Netherlands; View further author information
,
H. M. VerkooijenDepartment of Epidemiology, University Medical Center Utrecht, Utrecht, The Netherlands; ORCID Iconhttp://orcid.org/0000-0001-9480-1623View further author information
ORCID Icon,
W. J. VlesDepartment of Surgery, Ikazia Hospital, Rotterdam, The Netherlands; View further author information
,
J. M. P. G. M. de Vos-GeelenDepartment of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands; View further author information
,
J. W. WilminkDepartment of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands; View further author information
,
D. D. E. ZimmermanDepartment of Surgery, Elisabeth-Tweesteden Hospital, Tilburg, The NetherlandsView further author information
,
M. G. H. van OijenDepartment of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands; ;Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands; ORCID Iconhttp://orcid.org/0000-0001-7897-1710View further author information
ORCID Icon,
M. KoopmanDepartment of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; View further author information
,
M. G. H. BesselinkDepartment of Surgery, Academic Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; View further author information
,
H. W. M. van LaarhovenDepartment of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands; Correspondence[email protected]
View further author information
& for the Dutch Pancreatic Cancer Group, Dutch Upper GI Cancer Group and PLCRC working group. show all
Pages 195-202 | Received 18 Apr 2017, Accepted 20 Jun 2017, Published online: 19 Jul 2017

Citations (51)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Simone Augustinus, Thijmen Broekman, Geert-Jan Creemers, Lois A. Daamen, Susan van Dieren, Jan-Willem B. de Groot, Geert A. Cirkel, Marjolein Y. V. Homs, Hanneke W. M. van Laarhoven, Lobke van Leeuwen, Maartje Los, Saskia A. C. Luelmo, Martijn G. H. van Oijen, Leontine E. A. M. Spierings, Judith de Vos-Geelen, Marc G. Besselink & Johanna W. Wilmink. (2023) Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trial. Acta Oncologica 62:12, pages 1973-1978.
Read now
Mathijs L. Tomassen, Pim J. J. Damen, Helena M. Verkooijen, Max Peters, Janneke van der Stap, Anne S. R. van Lindert, Joost J. C. Verhoeff & Peter S. N. van Rossum. (2023) Feasibility and first results of the ‘Trials-within-Cohorts’ (TwiCs) design in patients undergoing radiotherapy for lung cancer. Acta Oncologica 62:3, pages 237-244.
Read now
Abdul Arif Khan, Vijay Nema & Zakir Khan. (2021) Current status of probiotics for prevention and management of gastrointestinal cancers. Expert Opinion on Biological Therapy 21:3, pages 413-422.
Read now
Lotte Keikes, Miriam Koopman, Martijn M. Stuiver, Valery E. P. P. Lemmens, Martijn G. H. van Oijen & Cornelis J. A. Punt. (2020) Practice variation on hospital level in the systemic treatment of metastatic colorectal cancer in The Netherlands: a population-based study. Acta Oncologica 59:4, pages 395-403.
Read now
Myrte Zijlstra, Lydia G. M. van der Geest, Hanneke W. M. van Laarhoven, Valery E. P. P. Lemmens, Lonneke V. van de Poll-Franse & Natasja J. H. Raijmakers. (2018) Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands. Acta Oncologica 57:9, pages 1185-1191.
Read now

Articles from other publishers (46)

A.M. Gehrels, A.D. Wagner, M.G. Besselink, R.H.A. Verhoeven, C.H.J. van Eijck, H.W.M. van Laarhoven, J.W. Wilmink & L.G. van der Geest. (2024) Gender differences in tumor characteristics, treatment allocation and survival in stage I-III pancreatic cancer: a nationwide study. European Journal of Cancer, pages 114117.
Crossref
Tara M. Mackay, Anouk E. J. Latenstein, Simone Augustinus, Lydia G. van der Geest, Auke Bogte, Bert A. Bonsing, Geert A. Cirkel, Lieke Hol, Olivier R. Busch, Marcel den Dulk, Lydi M. J.W. van Driel, Sebastiaan Festen, Derk-Jan A. de Groot, Jan-Willem B. de Groot, Bas Groot Koerkamp, Nadia Haj Mohammad, Joyce T. Haver, Erwin van der Harst, Ignace H. de Hingh, Marjolein Y. V. Homs, Maartje Los, Saskia A. C. Luelmo, Vincent E. de Meijer, Leonie Mekenkamp, I. Quintus Molenaar, Gijs A. Patijn, Rutger Quispel, Tessa E. H. Römkens, Hjalmar C. van Santvoort, Martijn W.J. Stommel, Niels G. Venneman, Robert C. Verdonk, Frederike G. I. van Vilsteren, Judith de Vos-Geelen, C. Henri van Werkhoven, Jeanin E. van Hooft, Casper H. J. van Eijck, Johanna W. Wilmink, Hanneke W. M. van Laarhoven, Marc G. Besselink, Hendrik Bos66, Koop Bosscha77, Lodewijk A. A. Brosens8.98.9, Geert-Jan Creemers1212, Wouter L. Curvers1313, Sarah Derks14.214.2, Susan van Dieren1.21.2, Erwin Jan M. van Geenen2020, Brigitte C.M. Haberkorn2424, G.J. Maarten Hemmink2727, Chantal Hoge2929, Akin Inderson3131, Maarten A.J.M. Jacobs32.232.2, Emile D. Kerver3333, Mike S.L. Liem3434, Hans Lubbinge3535, Jennifer M.J. Schreinemakers4343, Heidi Schut4444, Tom Seerden4545, Joanne Verheij48.248.2, Annelie Vulink5151, Caroline A. Wientjes5252, Fennie Wit5353, Frank J. Wessels5454 & Babs Zonderhuis55.255.2. (2024) Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands. JAMA Surgery 159:4, pages 429.
Crossref
Beverley Jane Nickolls, Clare Relton, Lars Hemkens, Merrick Zwarenstein, Sandra Eldridge, Stephen J McCall, Xavier Luke Griffin, Ratna Sohanpal, Helena M Verkooijen, Jonathon L Maguire & Kimberly A McCord. (2024) Randomised trials conducted using cohorts: a scoping review. BMJ Open 14:3, pages e075601.
Crossref
Felice N. van Erning, Grard A. P. Nieuwenhuijzen, Hanneke W. M. van Laarhoven, Camiel Rosman, Suzanne S. Gisbertz, Joos Heisterkamp, Sjoerd M. Lagarde, Marije Slingerland, Jan-Willem van den Berg, Ewout A. Kouwenhoven, Rob H. A. Verhoeven & Pauline A. J. Vissers. (2023) Gastrointestinal Symptoms After Resection of Esophagogastric Cancer: A Longitudinal Study on Their Incidence and Impact on Patient-Reported Outcomes. Annals of Surgical Oncology 30:13, pages 8203-8215.
Crossref
Steven C. Kuijper, Joost Besseling, Thomas Klausch, Marije Slingerland, Charlène J. van der Zijden, Ewout A. Kouwenhoven, Laurens V. Beerepoot, Nadia Haj Mohammad, Bastiaan R. Klarenbeek, Rob H.A. Verhoeven & Hanneke W.M. van Laarhoven. (2023) Assessing real-world representativeness of prospective registry cohorts in oncology: insights from patients with esophagogastric cancer. Journal of Clinical Epidemiology 164, pages 65-75.
Crossref
Pauline A.J. Vissers, Josianne C.H.B.M. Luijten, Valery E.P.P. Lemmens, Hanneke W.M. van Laarhoven, Marije Slingerland, Bas P.L. Wijnhoven, C. Rosman, Stella Mook, Joos Heisterkamp, Ellen M. Hendriksen, Suzanne S. Gisbertz, Grard A.P. Nieuwenhuijzen & Rob H.A. Verhoeven. (2023) The association between hospital variation in curative treatment for esophagogastric cancer and health-related quality of life and survival. European Journal of Surgical Oncology 49:10, pages 107019.
Crossref
L.F. van de Water, S.C. Kuijper, I. Henselmans, E.N. van Alphen, E.S. Kooij, M.M. Calff, L.V. Beerepoot, J. Buijsen, W.J. Eshuis, E.D. Geijsen, S.H.C. Havenith, F.F.B.M. Heesakkers, S. Mook, K. Muller, H.C. Post, H. Rütten, M. Slingerland, T. van Voorthuizen, H.W.M. van Laarhoven & E.M.A. Smets. (2023) Effect of a prediction tool and communication skills training on communication of treatment outcomes: a multicenter stepped wedge clinical trial (the SOURCE trial). eClinicalMedicine 64, pages 102244.
Crossref
Marieke Pape, Pauline A. J. Vissers, Marije Slingerland, Nadia Haj Mohammad, Peter S. N. van Rossum, Rob H. A. Verhoeven & Hanneke W. M. van Laarhoven. (2023) Long-term health-related quality of life in patients with advanced esophagogastric cancer receiving first-line systemic therapy. Supportive Care in Cancer 31:9.
Crossref
Rob Kessels, Anne M. May, Miriam Koopman & Kit C. B. Roes. (2023) The Trial within Cohorts (TwiCs) study design in oncology: experience and methodological reflections. BMC Medical Research Methodology 23:1.
Crossref
Nikki de Mul, Diede Verlaan, Jelle P Ruurda, Wilhelmina M U van Grevenstein, Jeroen Hagendoorn, Gert-Jan de Borst, Menno R Vriens, Remco de Bree, Ronald P Zweemer, Charles Vogely, Jelle L G Haitsma Mulier, Lisette M Vernooij, Johannes B Reitsma, Marcel R de Zoete, Janetta Top, Jan A J Kluijtmans, Imo E Hoefer, Peter Noordzij, Thijs Rettig, Marije Marsman, Anne Marie G A de Smet, Lennie Derde, Judith van Waes, Mienke Rijsdijk, Willem Jan M Schellekens, Marc J M Bonten, Arjen J C Slooter & Olaf L Cremer. (2023) Cohort profile of PLUTO: a perioperative biobank focusing on prediction and early diagnosis of postoperative complications. BMJ Open 13:4, pages e068970.
Crossref
Myrte Zijlstra, J. van Roij, I. Henselmans, H. W. M. van Laarhoven, G. J. Creemers, G. Vreugdenhil, E. J. M. Kuip, L. V. van de Poll-Franse & N. J. H. Raijmakers. (2023) Perception of prognosis and health-related quality of life in patients with advanced cancer: results of a multicentre observational study (eQuiPe). Supportive Care in Cancer 31:3.
Crossref
N. Schuring, E. Jezerskyte, M.I. van Berge Henegouwen, M.A.G. Sprangers, P. Lagergren, A. Johar, S.R. Markar, S.S. Gisbertz, Sheraz R. Markar, Giovanni Zaninotto, Carlo Castoro, Asif Johar, Pernilla Lagergren, Jessie A. Elliott, Suzanne S. Gisbertz, Christophe Mariette, Rita Alfieri, Jeremy Huddy, Viknesh Sounderajah, Eleonora Pinto, Marco Scarpa, Fredrik Klevebro, Berit Sunde, Conor F. Murphy, Christine Greene, Narayanasamy Ravi, Guillaume Piessen, Hylke Brenkman, Jelle P. Ruurda, Richard Van Hillegersberg, Sjoerd Lagarde, Bas Wijnhoven, Manuel Pera, José Roig, Sandra Castro, Robert Matthijsen, John Findlay, Stefan Antonowicz, Nick Maynard, Orla McCormack, Arun Ariyarathenam, Grant Sanders, Edward Cheong, Shameen Jaunoo, William Allum, Jan Van Lanschot, Magnus Nilsson, John V. Reynolds, Mark I. van Berge Henegouwen & George B. Hanna. (2023) Influence of postoperative complications following esophagectomy for cancer on quality of life: A European multicenter study. European Journal of Surgical Oncology 49:1, pages 97-105.
Crossref
D. Doppenberg, M. G. Besselink, C. H. J. van Eijck, M. P. W. Intven, B. Groot Koerkamp, G. Kazemier, H. W. M. van Laarhoven, M. Meijerink, I. Q. Molenaar, J. J. M. E. Nuyttens, R. van Os, H. C. van Santvoort, G. van Tienhoven, H. M. Verkooijen, E. Versteijne, J. W. Wilmink, F. J. Lagerwaard & A. M. E. Bruynzeel. (2022) Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design. BMC Cancer 22:1.
Crossref
L. A. Daamen, V. P. Groot, H. M. Verkooijen, I. Q. Molenaar & H. C. van Santvoort. (2022) Response to Comment on: “Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis”. Annals of Surgery 276:6, pages e1124-e1125.
Crossref
I. W. J. M. van Goor, L. A. Daamen, M. G. Besselink, A. M. E. Bruynzeel, O. R. Busch, G. A. Cirkel, B. Groot Koerkamp, N. Haj Mohammed, H. D. Heerkens, H. W. M. van Laarhoven, G. J. Meijer, J. Nuyttens, H. C. van Santvoort, G. van Tienhoven, H. M. Verkooijen, J. W. Wilmink, I. Q. Molenaar & M. P. W. Intven. (2022) A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE). Trials 23:1.
Crossref
Lonneke V van de Poll-Franse, Nicole Horevoorts, Dounya Schoormans, Sandra Beijer, Nicole P M Ezendam, Olga Husson, Simone Oerlemans, Sanne B Schagen, Geja J Hageman, Katrijn Van Deun, Corina van den Hurk, Mies van Eenbergen, Floortje Mols, Belle de Rooij, Natasja Raijmakers, Carla Vlooswijk, Cynthia Bonhof, Afke Ekels, Meeke Hoedjes, S J M van Cappellen – van Maldegem, Laurien Ham, Danielle van de Graaf & Janneke van Roij. (2022) Measuring Clinical, Biological, and Behavioral Variables to Elucidate Trajectories of Patient-Reported Outcomes: The PROFILES Registry. JNCI: Journal of the National Cancer Institute 114:6, pages 800-807.
Crossref
Esther N. Pijnappel, Willemieke P. M. Dijksterhuis, Mirjam A. G. Sprangers, Simone Augustinus, Judith de Vos-Geelen, Ignace H. J. T. de Hingh, Izaak Q. Molenaar, Olivier R. Busch, Marc G. Besselink, Johanna W. Wilmink & Hanneke W. M. van Laarhoven. (2022) The fear of cancer recurrence and progression in patients with pancreatic cancer. Supportive Care in Cancer 30:6, pages 4879-4887.
Crossref
Eva Versteijne, Mustafa Suker, Jesse V. Groen, Marc G. Besselink, Bert A. Bonsing, Koop Bosscha, Olivier R. Busch, Ignace H. J. T. de Hingh, Koert P. de Jong, I. Quintus Molenaar, Hjalmar C. van Santvoort, Helena M. Verkooijen, Casper H. Van Eijck & Geertjan van Tienhoven. (2022) External Validity of the Multicenter Randomized PREOPANC Trial on Neoadjuvant Chemoradiotherapy in Pancreatic Cancer. Annals of Surgery 275:5, pages 972-978.
Crossref
Tara M. Mackay, Willemieke P.M. Dijksterhuis, Anouk E.J. Latenstein, Lydia G. van der Geest, Mirjam A.G. Sprangers, Casper H.J. van Eijck, Marjolein Y.V. Homs, Saskia A.C. Luelmo, I. Quintus Molenaar, Hjalmar van Santvoort, Jennifer M.J. Schreinemakers, Johanna W. Wilmink, Marc G. Besselink, Hanneke W. van Laarhoven & Martijn G.H. van Oijen. (2022) The impact of cancer treatment on quality of life in patients with pancreatic and periampullary cancer: a propensity score matched analysis. HPB 24:4, pages 443-451.
Crossref
J.C.H.B.M. Luijten, G.A.P. Nieuwenhuijzen, M.N. Sosef, I.H.J.T. de Hingh, C. Rosman, J.P. Ruurda, P. van Duijvendijk, J. Heisterkamp, W.O. de Steur, H.W.M. van Laarhoven, M.G. Besselink, B. Groot Koerkamp, H.C. van Santvoort, V.E.P. Lemmens & P.A.J. Vissers. (2022) Impact of nationwide centralization of oesophageal, gastric, and pancreatic surgery on travel distance and experienced burden in the Netherlands. European Journal of Surgical Oncology 48:2, pages 348-355.
Crossref
E. Jezerskyte, M. I. van Berge Henegouwen, H. W. M. van Laarhoven, J. J. van Kleef, W. J. Eshuis, J. Heisterkamp, H. H. Hartgrink, C. Rosman, R. van Hillegersberg, M. C. C. M. Hulshof, M. A. G. Sprangers & S. S. Gisbertz. (2021) Postoperative Complications and Long-Term Quality of Life After Multimodality Treatment for Esophageal Cancer: An Analysis of the Prospective Observational Cohort Study of Esophageal-Gastric Cancer Patients (POCOP). Annals of Surgical Oncology 28:12, pages 7259-7276.
Crossref
Héctor G. van den BoornWillemieke P.M. DijksterhuisLydia G.M. van der GeestJudith de Vos-GeelenMarc G. Besselink, Johanna W. WilminkMartijn G.H. van OijenHanneke W.M. van Laarhoven. (2021) SOURCE-PANC: A Prediction Model for Patients With Metastatic Pancreatic Ductal Adenocarcinoma Based on Nationwide Population-Based Data. Journal of the National Comprehensive Cancer Network 19:9, pages 1045-1053.
Crossref
J. J. van Kleef, W. P. M. Dijksterhuis, H. G. van den Boorn, M. Prins, R. H. A. Verhoeven, S. S. Gisbertz, M. Slingerland, N. Haj Mohammad, G.-J. Creemers, K. J. Neelis, J. Heisterkamp, C. Rosman, J. P. Ruurda, E. A. Kouwenhoven, L. V. van de Poll-Franse, M. G. H. van Oijen, M. A. G. Sprangers & H. W. M. van Laarhoven. (2021) Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study. Gastric Cancer.
Crossref
E. Jezerskyte, L.M. Saadeh, E.R.C. Hagens, M.A.G. Sprangers, L. Noteboom, H.W.M. van Laarhoven, W.J. Eshuis, M.C.C.M. Hulshof, M.I. van Berge Henegouwen & S.S. Gisbertz. (2021) Long-Term Quality of Life Following Transthoracic and Transhiatal Esophagectomy for Esophageal Cancer. Journal of Gastrointestinal Surgery 25:7, pages 1657-1666.
Crossref
Anke Richters, Richard P Meijer, Niven Mehra, Joost L Boormans, Antoine G van der Heijden, Michiel S van der Heijden, Lambertus A Kiemeney & Katja K Aben. (2021) Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the ‘trials within cohorts’ study ProBCI. BMJ Open 11:5, pages e047256.
Crossref
Willemieke P.M. DijksterhuisAnouk E.J. LatensteinJessy Joy van KleefRob H.A. VerhoevenJeanne H.M. de VriesMarije SlingerlandElles SteenhagenJoos HeisterkampLiesbeth M. Timmermans, Marian A.E. de van der SchuerenMartijn G.H. van OijenSandra BeijerHanneke W.M. van Laarhoven. (2021) Cachexia and Dietetic Interventions in Patients With Esophagogastric Cancer: A Multicenter Cohort Study. Journal of the National Comprehensive Cancer Network 19:2, pages 144-152.
Crossref
T. M. Mackay, F. J. Smits, A. E. J. Latenstein, A. Bogte, B. A. Bonsing, H. Bos, K. Bosscha, L. A. A. Brosens, L. Hol, O. R. C. Busch, G. J. Creemers, W. L. Curvers, M. den Dulk, S. van Dieren, L. M. J. W. van Driel, S. Festen, E. J. M. van Geenen, L. G. van der Geest, D. J. A. de Groot, J. W. B. de Groot, N. Haj Mohammad, B. C. M. Haberkorn, J. T. Haver, E. van der Harst, G. J. M. Hemmink, I. H. de Hingh, C. Hoge, M. Y. V. Homs, N. C. van Huijgevoort, M. A. J. M. Jacobs, E. D. Kerver, M. S. L. Liem, M. Los, H. Lubbinge, S. A. C. Luelmo, V. E. de Meijer, L. Mekenkamp, I. Q. Molenaar, M. G. H. van Oijen, G. A. Patijn, R. Quispel, L. B. van Rijssen, T. E. H. Römkens, H. C. van Santvoort, J. M. J. Schreinemakers, H. Schut, T. Seerden, M. W. J. Stommel, A. J. ten Tije, N. G. Venneman, R. C. Verdonk, J. Verheij, F. G. I. van Vilsteren, J. de Vos-Geelen, A. Vulink, C. Wientjes, F. Wit, F. J. Wessels, B. Zonderhuis, C. H. van Werkhoven, J. E. van Hooft, C. H. J. van Eijck, J. W. Wilmink, H. W. M. van Laarhoven & M. G. Besselink. (2020) Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1): a multicenter stepped-wedge cluster randomized controlled trial. Trials 21:1.
Crossref
Janneke van Roij, Myrte Zijlstra, Laurien Ham, Linda Brom, Heidi Fransen, Art Vreugdenhil, Natasja Raijmakers, Lonneke van de Poll-Franse, Art Vreugdenhil, Maggy Youssef-ELSoud, Geert-Jan Creemers, Ben van den Borne, Wouter de Jong, Arnold Baars, Marieke van den Beuken - van Everdingen, Evelien Kuip, René Bunnik, Mathijs Hendriks, Caroline Mandigers, Jean-Paul van Basten, Vivian van Kampen – van den Boogaart, Philo Werner, Lia van Zuylen, Alexander de Graeff, Anne van Lindert, Marcel Soesan, Jarmo Hunting, Arno Smals, Linda van de Winkel, Gerben Stege, Liese Verhaert, Natascha Peters, Manon Pepels, Tineke Smilde, Peter Nieboer, Sander de Hosson, Marien den Boer, Cordula Pitz, Rick Heyne, Manuel Tjin-A-Ton, Annemieke van der Padt – Pruijsten, Paul van den Berg, Frans Krouwels, Lobke van Leeuwen-Snoeks, Femke van der Meer, Allert Vos, Gerrit Jan Veldhuis, Boelo Poppema, Martine Thijs-Visser, Roxane Heller-Baan, Marjolein van Laren, Karen Maassen van den Brink, Gea Douma, Jeroen Kloover, Dirkje Sommeijer, Lemke Pronk, Ellen Janssens - van Vliet, Lilly-Ann van der Velden, Emma Hafkamp, Henk Codrington, Svitlana Tarasevych, Aart van Bochove, Annemieke van der Padt – Pruijsten, Jaap de Boer & Geraldine Vink. (2020) Prospective cohort study of patients with advanced cancer and their relatives on the experienced quality of care and life (eQuiPe study): a study protocol. BMC Palliative Care 19:1.
Crossref
I. van den Berg, S. van de Weerd, J. M. L. Roodhart, G. R. Vink, R. R. J. Coebergh van den Braak, C. R. Jimenez, S. G. Elias, D. van Vliet, M. Koelink, E. Hong, W. M. U. van Grevenstein, M. G. H. van Oijen, R. G. H. Beets-Tan, J. H. J. M. van Krieken, J. N. M. IJzermans, J. P. Medema & M. Koopman. (2020) Improving clinical management of colon cancer through CONNECTION, a nation-wide colon cancer registry and stratification effort (CONNECTION II trial): rationale and protocol of a single arm intervention study. BMC Cancer 20:1.
Crossref
Tara M. Mackay, Anouk E.J. Latenstein, Bert A. Bonsing, Marco J. Bruno, Casper H.J. van Eijck, Bas Groot Koerkamp, Ignace H.J.T. de Hingh, Marjolein Y.V. Homs, Jeanin E. van Hooft, Hanneke W. van Laarhoven, I. Quintus Molenaar, Hjalmar C. van Santvoort, Martijn W.J. Stommel, Judith de Vos-Geelen, Johanna W. Wilmink, Olivier R. Busch, Lydia G. van der Geest & Marc G. Besselink. (2020) Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up. Pancreatology 20:8, pages 1723-1731.
Crossref
Anouk E. J. Latenstein, Willemieke P. M. Dijksterhuis, Tara M. Mackay, Sandra Beijer, Casper H. J. van Eijck, Ignace H. J. T. de Hingh, I. Quintus Molenaar, Martijn G. H. van Oijen, Hjalmar C. van Santvoort, Marian A. E. de van der Schueren, Judith de Vos‐Geelen, Jeanne H. M. de Vries, Johanna W. Wilmink, Marc G. Besselink & Hanneke W. M. van Laarhoven. (2020) Cachexia, dietetic consultation, and survival in patients with pancreatic and periampullary cancer: A multicenter cohort study. Cancer Medicine 9:24, pages 9385-9395.
Crossref
Tara M. MackayLennart B. van RijssenJurr O. AndriessenMustafa SukerGeert-Jan CreemersFerry A. EskensIgnace H. de HinghLonneke V. van de Poll-Franse, Mirjam A.G. Sprangers, Olivier R. BuschJohanna W. WilminkCasper H. van EijckMarc G. BesselinkHanneke W. van Laarhoven_ _. (2020) Patient Satisfaction and Quality of Life Before and After Treatment of Pancreatic and Periampullary Cancer: A Prospective Multicenter Study. Journal of the National Comprehensive Cancer Network 18:6, pages 704-711.
Crossref
M.J.M. van Velzen, S. Derks, N.C.T. van Grieken, N. Haj Mohammad & H.W.M. van Laarhoven. (2020) MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma. Cancer Treatment Reviews 86, pages 102024.
Crossref
B. F. Kingma, P. Rauwerdink, H. J. F. Brenkman, J. P. Ruurda & R. van Hillegersberg. (2019) Do esophageal cancer survivors work after esophagectomy and do health problems impact their work? A cross-sectional study. Journal of Cancer Survivorship 14:3, pages 253-260.
Crossref
Marin Strijker, Tara M. Mackay, Bert A. Bonsing, Marco J. Bruno, Casper H. J. van Eijck, Ignace H. J. T. de Hingh, Bas Groot Koerkamp, Hanneke W. van Laarhoven, I. Quintus Molenaar, Hjalmar C. van Santvoort, Geertjan van Tienhoven, Johanna W. Wilmink, Sako Zeverijn, Olivier R. BuschMarc G. Besselink. (2020) Establishing and Coordinating a Nationwide Multidisciplinary Study Group: Lessons Learned by the Dutch Pancreatic Cancer Group. Annals of Surgery 271:4, pages e102-e104.
Crossref
E. Jezerskyte, L. M. Saadeh, E. R. C. Hagens, M. A. G. Sprangers, L. Noteboom, H. W. M. van Laarhoven, W. J. Eshuis, M. I. van Berge Henegouwen & S. S. Gisbertz. (2019) Long‐Term Quality of Life After Total Gastrectomy Versus Ivor Lewis Esophagectomy. World Journal of Surgery 44:3, pages 838-848.
Crossref
Tara M. Mackay, F. Jasmijn Smits, Daphne Roos, Bert A. Bonsing, Koop Bosscha, Olivier R. Busch, Geert-Jan Creemers, Ronald M. van Dam, Casper H.J. van Eijck, Michael F. Gerhards, Jan Willem B. de Groot, Bas Groot Koerkamp, Nadia Haj Mohammad, Erwin van der Harst, Ignace H.J.T. de Hingh, Marjolein Y.V. Homs, Geert Kazemier, Mike S.L. Liem, Vincent E. de Meijer, I. Quintus Molenaar, Vincent B. Nieuwenhuijs, Hjalmar C. van Santvoort, George P. van der Schelling, Martijn W.J. Stommel, Albert Jan ten Tije, Judith de Vos-Geelen, Fennie Wit, Johanna W. Wilmink, Hanneke W.M. van Laarhoven & Marc G. Besselink. (2020) The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis. HPB 22:2, pages 233-240.
Crossref
Stijn van Roessel, Tara M. Mackay, Susan van Dieren, George P. van der Schelling, Vincent B. Nieuwenhuijs, Koop Bosscha, Edwin van der Harst, Ronald M. van Dam, Mike S. L. Liem, Sebastiaan Festen, Martijn W. J. Stommel, Daphne Roos, Fennie Wit, I. Quintus Molenaar, Vincent E. de Meijer, Geert KazemierIgnace H. J. T. de Hingh, Hjalmar C. van Santvoort, Bert A. Bonsing, Olivier R. Busch, Bas Groot Koerkamp & Marc G. Besselink. (2020) Textbook Outcome. Annals of Surgery 271:1, pages 155-162.
Crossref
L. V. van de Poll-Franse, J. B. Prins & I. M. Verdonck-de Leeuw. 2020. Leerboek oncologie. Leerboek oncologie 681 691 .
Tom van den Ende, Frank A. Abe Nijenhuis, Héctor G. van den Boorn, Emil ter Veer, Maarten C. C. M. Hulshof, Suzanne S. Gisbertz, Martijn G. H. van Oijen & Hanneke W. M. van Laarhoven. (2019) COMplot, A Graphical Presentation of Complication Profiles and Adverse Effects for the Curative Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis. Frontiers in Oncology 9.
Crossref
van den Ende, ter Veer, Mali, van Berge Henegouwen, Hulshof, van Oijen & van Laarhoven. (2019) Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis. Cancers 11:4, pages 530.
Crossref
T M Mackay, U F Wellner, L B van Rijssen, T F Stoop, O R Busch, B Groot Koerkamp, D Bausch, E Petrova, M G Besselink, T Keck, H C van Santvoort, I Q Molenaar, N Kok, S Festen, C H J van Eijck, B A Bonsing, J Erdmann, I de Hingh, H J Buhr & C Klinger. (2019) Variation in pancreatoduodenectomy as delivered in two national audits. British Journal of Surgery 106:6, pages 747-755.
Crossref
Astrid E. Slagter, Edwin P. M. Jansen, Hanneke W. M. van Laarhoven, Johanna W. van Sandick, Nicole C. T. van Grieken, Karolina Sikorska, Annemieke Cats, Pietje Muller-Timmermans, Maarten C. C. M. Hulshof, Henk Boot, Maartje Los, Laurens V. Beerepoot, Frank P. J. Peters, Geke A. P. Hospers, Boudewijn van Etten, Henk H. Hartgrink, Mark I. van Berge Henegouwen, Grard A. P. Nieuwenhuijzen, Richard van Hillegersberg, Donald L. van der Peet, Heike I. Grabsch & Marcel Verheij. (2018) CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer. BMC Cancer 18:1.
Crossref
H. J. F. Brenkman, E. C. Gertsen, E. Vegt, R. van Hillegersberg, M. I. van Berge Henegouwen, S. S. Gisbertz, M. D. P. Luyer, G. A. P. Nieuwenhuijzen, J. J. B. van Lanschot, S. M. Lagarde, W. O. de Steur, H. H. Hartgrink, J. H. M. B. Stoot, K. W. E. Hulsewe, E. J. Spillenaar Bilgen, M. J. van Det, E. A. Kouwenhoven, D. L. van der Peet, F. Daams, J. W. van Sandick, N. C. T. van Grieken, J. Heisterkamp, B. van Etten, J. W. Haveman, J. P. Pierie, F. Jonker, A. Y. Thijssen, E. J. T. Belt, P. van Duijvendijk, E. Wassenaar, H. W. M. van Laarhoven, F. J. Wessels, N. Haj Mohammad, H. F. van Stel, G. W. J. Frederix, P. D. Siersema & J. P. Ruurda. (2018) Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study). BMC Cancer 18:1.
Crossref
Paul M. Jeene, Hanneke W.M. van Laarhoven & Maarten C.C.M. Hulshof. (2018) The role of definitive chemoradiation in patients with non-metastatic oesophageal cancer. Best Practice & Research Clinical Gastroenterology 36-37, pages 53-59.
Crossref
R. Troisi, T. Bjørge, M. Gissler, T. Grotmol, C. M. Kitahara, S. M. Myrtveit Sæther, A. G. Ording, C. Sköld, H. T. Sørensen, B. Trabert & I. Glimelius. (2018) The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence. Journal of Internal Medicine 283:5, pages 430-445.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.